Patent classifications
C12N5/0031
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Anti-VEGF protein compositions and methods for producing the same
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Anti-VEGF protein compositions and methods for producing the same
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Culture media comprising n-Acyl-X-glutamine dipeptides
Disclosed herein is a cell culture media containing L-glutamine from a set of N-acylated dipeptides Acyl-X-Q, and L-glutamine from a set of other glutamine-sources Qsource in a defined molar ratio R=n(Acyl-X-Q)/n(Qsource), wherein the variables X, Q, Acyl, R, n(Acyl-X-Q) and n(Qsource) are defined in the general disclosure. Processes of using the cell culture media are also described herein.
SERUM-FREE CELL CULTURE MEDIUM
The specification describes an improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Ornithine, or a combination of ornithine and putrescine can be added to serum-free media or chemically defined media to improve viable cell density, to reduce cell doubling time, and to increase the production of a protein of interest.
Methods of minimizing glycoprotein agregation in CHO cell production
In accordance with the present invention, CHO cells expressing a recombinant polypeptide of interest are grown in media where the amino acids, vitamins, phosphate, lipids and/or antioxidant optimization is utilized to manipulate and/or control the protein quality attributes of the polypeptides. Polypeptides expressed in accordance with the present invention may be advantageously used in the preparation of pharmaceutical compositions.
ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Anti-VEGF protein compositions and methods for producing the same
The present disclosure pertains compositions comprising anti-VEGF proteins and methods for producing such compositions.